AI Accessibility Checklist for Healthcare & Biotech

Document accessibility goals alongside clinical, technical, and regulatory requirements before model development starts. In healthcare and biotech, this should include patient portals, diagnostic interfaces, informed consent flows, lab dashboards, and any AI-assisted communication touchpoints.

Identify clinicians, patients, caregivers, clinical trial participants, lab technicians, and medical affairs teams who may rely on assistive technologies. Include users with low vision, hearing loss, motor impairments, cognitive differences, and limited health literacy to avoid excluding key populations.

Give one accountable lead responsibility for coordinating accessibility decisions across UX, ML, regulatory, privacy, and clinical operations. This reduces the common problem where accessibility is treated as a design issue instead of a cross-functional risk area.

Add accessibility-related failure modes to your risk register, such as unreadable outputs, inaccessible alerts, or speech-only interactions that fail in noisy clinical settings. If the system influences care decisions, tie these risks into existing safety management processes and post-market monitoring plans.

Define testable thresholds such as screen reader compatibility for patient intake, caption accuracy for telehealth summaries, keyboard-only completion rates for EHR tasks, and readability targets for AI-generated patient education. Measurable criteria make vendor reviews and release approvals much more defensible.

Check how accessibility expectations intersect with HIPAA, GDPR, FDA software guidance, EU MDR, and local digital accessibility requirements in your market. This is especially important for software used in care delivery, remote monitoring, clinical trials, or patient support programs.

Evaluate whether datasets underrepresent patients with speech impairments, atypical movement patterns, low vision workflows, or assistive device usage. In clinical AI, poor representation can reduce performance for exactly the groups most likely to face access barriers.

If you use speech recognition for ambient scribing, virtual triage, or patient support, validate performance across accents, dysarthria, stuttering, ventilator noise, mask use, and telehealth audio conditions. Generic benchmarks often miss the realities of care environments.

Prompt and tune generative systems to produce patient instructions, test explanations, and care navigation steps at appropriate reading levels without losing clinical accuracy. This is especially valuable in oncology, rare disease, and chronic care programs where communication burden is high.

Generate summaries, alerts, and recommendations in predictable structures with headings, lists, and labeled fields rather than dense paragraphs. Structured outputs are easier for screen readers, patient portals, and downstream care coordination systems to interpret correctly.

For systems processing pathology images, radiology reports, scanned consent forms, or lab PDFs, confirm they preserve tags, labels, alt text, and machine-readable content where applicable. Accessibility breaks when AI pipelines turn navigable documents into inaccessible image blobs.

Verify that AI summarization does not omit boxed warnings, contraindications, accessibility instructions for medical devices, or key adverse event language. Summaries used in pharmacovigilance, med info, or patient support must retain critical safety context in accessible formats.

Check that clinicians and coordinators can navigate AI-assisted chart review, trial enrollment screens, CDS alerts, and lab workflow tools without a mouse. Keyboard accessibility matters in fast-paced environments and for users with motor impairments or repetitive strain limitations.

Test AI-powered scheduling, symptom checkers, genomic report viewers, and remote monitoring dashboards with NVDA, JAWS, and VoiceOver where relevant. Healthcare interfaces often fail because dynamic content and alerts are not announced correctly.

If you use AI to create telehealth recaps, medication instructions, training modules, or patient education videos, provide synchronized captions and downloadable transcripts. This supports Deaf and hard-of-hearing users and improves comprehension in noisy hospital settings.

Clinical and laboratory systems often use color-coded urgency states, but accessibility requires icons, text labels, and programmatic status indicators too. This reduces risk for users with color vision deficiency and helps in dimly lit or high-glare environments.

Patient portals, trial apps, and clinician dashboards should remain fully functional at high zoom levels and with strong contrast settings. Accessibility fixes must be tested carefully in validated environments so they do not break regulated workflows or audit trails.

For clinical trials and digital therapeutics, ensure AI-assisted consent tools support screen readers, plain-language summaries, captions, translated text, and easy navigation. Inaccessible consent can create ethical and recruitment problems, especially in decentralized studies.

If a voice bot, symptom triage assistant, or automated intake tool cannot serve a user effectively, offer a quick handoff to human support, text chat, or alternative input methods. This is essential in healthcare, where failure to complete a task can delay care or study participation.

Speech input, screen sharing, live captions, and AI transcription can unintentionally expose protected health information if they are not configured securely. Evaluate where data is processed, stored, and displayed, especially in exam rooms, research sites, and telehealth sessions.

Accessible summaries, transcripts, and alternative-format reports should still follow minimum necessary access rules. This matters when patient support teams, investigators, and clinicians use the same platform but should not see the same data scope.

Do not rely on marketing statements alone when purchasing ambient documentation tools, trial platforms, or medical AI SaaS. Request VPATs, accessibility test evidence, remediation timelines, and contract language that covers healthcare-specific use cases.

Analytics on caption use, zoom preferences, speech corrections, or keyboard navigation can reveal disability-related information. Coordinate with privacy counsel and security teams so observability does not conflict with consent, retention, or data minimization requirements.

Capture accessibility test results, known limitations, and remediation decisions as part of software validation and change control. This is especially useful for medical device software, GxP-adjacent systems, and enterprise platforms subject to audit or customer review.

Treat inaccessible medication instructions, unreadable trial alerts, or broken screen reader paths as operational incidents with defined triage owners. Fast response matters because accessibility defects in healthcare can quickly become patient safety or compliance issues.

Include real users who rely on assistive technology in formative and summative testing, rather than inferring accessibility from design reviews alone. In healthcare and biotech, this should cover clinical tasks, patient education, enrollment, adverse event reporting, and support workflows.

Track whether users can finish key tasks such as refill requests, symptom reporting, protocol review, or genomic result interpretation using captions, screen readers, high contrast, or keyboard navigation. Accessibility metrics should be tied to business and safety outcomes, not just compliance checklists.

Generative output changes, front-end redesigns, or new CDS components can silently break accessibility. Build regression tests into your release pipeline so improvements in model quality do not come at the expense of patient or clinician access.

Set up periodic reviews for speech recognition accuracy, caption quality, text simplification fidelity, and interaction failure rates across disability-relevant scenarios. Drift can appear after deployment as new populations, clinical vocabularies, or devices enter the workflow.

Prioritize fixes based on whether an issue blocks access to diagnosis, treatment instructions, trial participation, or safety information. A missing alt label on a marketing page is not the same as an inaccessible infusion schedule in a patient portal.

Add clear reporting paths in patient apps, clinician tools, and research portals so users can flag inaccessible AI outputs or workflows. Feed that signal into product, compliance, and quality teams instead of treating it as routine customer support noise.

If your platform has current gaps, document them transparently along with workarounds and target remediation dates. This helps provider systems, sponsors, and biotech partners make informed deployment decisions and reduces procurement friction.